Supply of Potassium Chloride Extended-Release Tablets

The contract entails the procurement and delivery of 1,000 BT of Potassium Chloride Extended-Release Tablets, identified by NSN 6505012578457 and NDC 42291-0507-01, to be supplied under FOB destination terms ensuring the vendor assumes responsibility for transportation and delivery risk until the product reaches the designated destination. The medication must fully comply with all federal regulations and Department of Defense standards, including quality, packaging, labeling, and safety requirements relevant to pharmaceuticals used in military healthcare systems. The procurement is managed under a subcontract by the Defense Logistics Agency, part of the Department of Defense, with the NAICS code 325412 indicating classification within pharmaceutical and biological product manufacturing. The solicitation was posted on August 9, 2026, and is linked to contract SPE2DX25D8022 with delivery order SPE2D926F8056. The place of performance and point of contact details are not specified, indicating that delivery location and coordination may be determined post-award based on operational needs. The contract does not include a set-aside designation, meaning it is open to all eligible contractors regardless of business size or status. All activities under this contract must align with the Defense Logistics Agency’s procurement protocols and timelines, ensuring timely and compliant delivery of critical pharmaceutical supplies to support military medical readiness.